Alkermes Completes Acquisition of Rodin Therapeutics

Acquisition Expands Alkermes' Research and Development Efforts to Include Small Molecule Therapeutics for SynaptopathiesDUBLIN, Nov. 25, 2019 -- (Healthcare Sales & Marketing Network)-- Alkermes plc (Nasdaq: ALKS) today announced that it has complete...Biopharmaceuticals, Neurology, Mergers & Acquisitions
Alkermes, Rodin Therapeutics